Global Substance Abuse Treatment market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Abuse Type;

Alcohol Dependence, Tobacco/Nicotine Addiction, Drug Abuse, and Others

By Treatment Setting;

Outpatient Treatment, Inpatient Treatment, Residential Treatment Facilities, and Detoxification Centers

By Distribution Channel;

Hospital Pharmacies, Retail Pharmacies & Drug Store, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn379271304 Published Date: June, 2025 Updated Date: July, 2025

Substance Abuse Treatment market Overview

Substance Abuse Treatment market (USD Million)

Substance Abuse Treatment market Market was valued at USD 10,087.06 million in the year 2024. The size of this market is expected to increase to USD 18,380.41 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.0%.


Global Substance Abuse Treatment market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 9.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)9.0 %
Market Size (2024)USD 10,087.06 Million
Market Size (2031)USD 18,380.41 Million
Market ConcentrationMedium
Report Pages389
10,087.06
2024
18,380.41
2031

Major Players

  • Accord Healthcare
  • Amphastar Pharmaceuticals
  • Apotex
  • BioCorRx
  • Cipla
  • Glenmark
  • INSYS Therapeutics
  • LFB Group

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Substance Abuse Treatment market

Fragmented - Highly competitive market without dominant players


The Substance Abuse Treatment Market is gaining momentum due to growing reliance on prescription medications, alcohol, and opioids. Around 65% of individuals in care benefit from structured behavioral therapy programs, creating significant opportunities for specialized treatment solutions. The rise of evidence-backed methods is promoting innovation in recovery plans and enhancing patient outcomes across various care models.

Technology Driving Accessible Recovery Solutions
Technology now supports around 58% of treatment protocols, with digital platforms offering remote therapy and real-time progress tracking. These innovations are enabling wider expansion of treatment reach, especially through telehealth and mobile applications. Providers are developing strategies to maintain patient engagement remotely while promoting collaboration across clinical teams and caregivers to support long-term recovery.

Collaborative Campaigns and Policy Support
Over 60% of recovery initiatives are now supported through public-private collaboration, highlighting the role of education and awareness in driving adoption. These partnerships are part of evolving strategies aimed at reducing stigma and promoting early-stage intervention. Mergers between healthcare and research sectors are facilitating advanced recovery models and boosting service innovation through shared expertise.

Future of Personalized and Predictive Treatment Models
More than 55% of providers are implementing predictive tools and analytics to better personalize care plans. These data-driven models represent the next phase of technological advancement in the market. With the continuous growth of smart recovery systems, treatment centers are investing in scalable, tailored solutions that promote wider expansion and open new opportunities for collaborative care.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Abuse Type
    2. Market Snapshot, By Treatment Setting
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Region
  4. Substance Abuse Treatment market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Prevalence
        2. Government support
        3. Treatment advancements
        4. Awareness
      2. Restraints
        1. Stigma
        2. Limited access
        3. Funding constraints
        4. Regulatory hurdles
      3. Opportunities
        1. Telemedicine
        2. Digital therapeutics
        3. Personalized medicine
        4. Community-based programs
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Substance Abuse Treatment market, By Abuse Type, 2021 - 2031 (USD Million)
      1. Alcohol dependence
      2. Tobacco/Nicotine addiction
      3. Drug abuse
      4. Others
    2. Substance Abuse Treatment market, By Treatment Setting, 2021 - 2031 (USD Million)
      1. Outpatient Treatment
      2. Inpatient Treatment
      3. Residential Treatment Facilities
      4. Detoxification Centers
      Substance Abuse Treatment market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Hospital Pharmacies
      2. Retail Pharmacies and Drug Store
      3. Others
    3. Substance Abuse Treatment market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Accord Healthcare
      2. Amphastar Pharmaceuticals
      3. Apotex
      4. BioCorRx
      5. Cipla
      6. Glenmark
      7. INSYS Therapeutics
      8. LFB Group
  7. Analyst Views
  8. Future Outlook of the Market